Søren Zöga Diederichsen1, Ketil Jørgen Haugan2, Axel Brandes3, Mathias Buus Lanng4, Claus Graff4, Derk Krieger5, Christian Kronborg6, Anders Gaarsdal Holst7, Lars Køber8, Søren Højberg9, Jesper Hastrup Svendsen10. 1. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: Soeren.Zoega.Diederichsen@regionh.dk. 2. Department of Cardiology, Zealand University Hospital, Roskilde, Denmark. 3. Department of Cardiology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. 4. Department of Health Science and Technology, Aalborg University, Aalborg, Denmark. 5. University Hospital Zurich, University of Zurich, Zurich, Switzerland; Stroke Unit, Mediclinic City Hospital, Dubai, United Arab Emirates. 6. Department of Business and Economics, University of Southern Denmark, Odense, Denmark. 7. Laboratory for Molecular Cardiology, Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 8. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 9. Department of Cardiology, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark. 10. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Laboratory for Molecular Cardiology, Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: As new heart rhythm monitoring technologies emerge, subclinical atrial fibrillation (AF) signifies a future challenge to health care systems. The pathological characteristics of this condition are largely unknown. OBJECTIVES: This study sought to characterize the natural history of subclinical AF in at-risk patients from the general population. METHODS: The authors studied 590 individuals ≥70 years of age with ≥1 of hypertension, diabetes, previous stroke, or heart failure, without history of AF, undergoing long-term implantable loop recorder monitoring as part of the LOOP (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals) study. Baseline assessments included N-terminal pro-B-type natriuretic peptide (NT-proBNP). All day-to-day heart rhythm and symptom data were extracted from the device. Endpoints included AF burden, AF progression, symptom reports, and heart rate during AF. RESULTS: A total of 685,445 monitoring days were available for analysis. Adjudicated AF episodes lasting ≥6 min were detected in 205 participants (35%). The AF burden was median 0.13% (interquartile range: 0.03% to 1.05%) of the monitoring time and changed by a factor of 1.31 (95% CI: 1.02 to 1.68) per doubling of NT-proBNP. AF episodes were present 2.7% (interquartile range: 1.0% to 15.7%) of monitoring days after debut. Progression to 24-h episodes was seen in 33 of the AF patients (16%), whereas 46 (22%) had no AF episodes in the last 6 months of monitoring or longer. Symptoms were absent in 185 (90%) at debut, and 178 (87%) never reported AF-related symptoms during follow-up. The averaged heart rate during AF was 96 (interquartile range: 83 to 114) beats/min, 24 (interquartile range: 9 to 41) beats/min faster than daytime sinus rates. CONCLUSIONS: Although previously unknown AF was highly prevalent, the burden was low, and progression was limited. In addition, symptoms were scarce, and the heart rate was only modestly elevated. (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals [LOOP]; NCT02036450).
RCT Entities:
BACKGROUND: As new heart rhythm monitoring technologies emerge, subclinical atrial fibrillation (AF) signifies a future challenge to health care systems. The pathological characteristics of this condition are largely unknown. OBJECTIVES: This study sought to characterize the natural history of subclinical AF in at-risk patients from the general population. METHODS: The authors studied 590 individuals ≥70 years of age with ≥1 of hypertension, diabetes, previous stroke, or heart failure, without history of AF, undergoing long-term implantable loop recorder monitoring as part of the LOOP (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals) study. Baseline assessments included N-terminal pro-B-type natriuretic peptide (NT-proBNP). All day-to-day heart rhythm and symptom data were extracted from the device. Endpoints included AF burden, AF progression, symptom reports, and heart rate during AF. RESULTS: A total of 685,445 monitoring days were available for analysis. Adjudicated AF episodes lasting ≥6 min were detected in 205 participants (35%). The AF burden was median 0.13% (interquartile range: 0.03% to 1.05%) of the monitoring time and changed by a factor of 1.31 (95% CI: 1.02 to 1.68) per doubling of NT-proBNP. AF episodes were present 2.7% (interquartile range: 1.0% to 15.7%) of monitoring days after debut. Progression to 24-h episodes was seen in 33 of the AFpatients (16%), whereas 46 (22%) had no AF episodes in the last 6 months of monitoring or longer. Symptoms were absent in 185 (90%) at debut, and 178 (87%) never reported AF-related symptoms during follow-up. The averaged heart rate during AF was 96 (interquartile range: 83 to 114) beats/min, 24 (interquartile range: 9 to 41) beats/min faster than daytime sinus rates. CONCLUSIONS: Although previously unknown AF was highly prevalent, the burden was low, and progression was limited. In addition, symptoms were scarce, and the heart rate was only modestly elevated. (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals [LOOP]; NCT02036450).
Authors: Emelia J Benjamin; Alan S Go; Patrice Desvigne-Nickens; Christopher D Anderson; Barbara Casadei; Lin Y Chen; Harry J G M Crijns; Ben Freedman; Mellanie True Hills; Jeff S Healey; Hooman Kamel; Dong-Yun Kim; Mark S Link; Renato D Lopes; Steven A Lubitz; David D McManus; Peter A Noseworthy; Marco V Perez; Jonathan P Piccini; Renate B Schnabel; Daniel E Singer; Robert G Tieleman; Mintu P Turakhia; Isabelle C Van Gelder; Lawton S Cooper; Sana M Al-Khatib Journal: Circulation Date: 2021-01-25 Impact factor: 29.690
Authors: Narcis Tribulova; Lin Hai Kurahara; Peter Hlivak; Katsuya Hirano; Barbara Szeiffova Bacova Journal: Int J Mol Sci Date: 2020-04-19 Impact factor: 5.923
Authors: Ruben R De With; Ömer Erküner; Michiel Rienstra; Bao-Oanh Nguyen; Frank W J Körver; Dominik Linz; Hugo Cate Ten; Henri Spronk; Abraham A Kroon; Alexander H Maass; Yuri Blaauw; Robert G Tieleman; Martin E W Hemels; Joris R de Groot; Arif Elvan; Mirko de Melis; Coert O S Scheerder; Meelad I H Al-Jazairi; Ulrich Schotten; Justin G L M Luermans; Harry J G M Crijns; Isabelle C Van Gelder Journal: Europace Date: 2020-08-01 Impact factor: 5.214
Authors: Dora Csengeri; Ngoc-Anh Sprünker; Augusto Di Castelnuovo; Teemu Niiranen; Julie Kk Vishram-Nielsen; Simona Costanzo; Stefan Söderberg; Steen M Jensen; Erkki Vartiainen; Maria Benedetta Donati; Christina Magnussen; Stephan Camen; Francesco Gianfagna; Maja-Lisa Løchen; Frank Kee; Jukka Kontto; Ellisiv B Mathiesen; Wolfgang Koenig; Blankenberg Stefan; Giovanni de Gaetano; Torben Jørgensen; Kari Kuulasmaa; Tanja Zeller; Veikko Salomaa; Licia Iacoviello; Renate B Schnabel Journal: Eur Heart J Date: 2021-03-21 Impact factor: 29.983
Authors: Giuseppe Boriani; Marco Vitolo; Igor Diemberger; Marco Proietti; Anna Chiara Valenti; Vincenzo Livio Malavasi; Gregory Y H Lip Journal: Cardiovasc Res Date: 2021-06-16 Impact factor: 13.081
Authors: Ravi B Patel; Joseph A Delaney; Mo Hu; Harnish Patel; Jeanette Cheng; John Gottdiener; Jorge R Kizer; Gregory M Marcus; Mintu P Turakhia; Rajat Deo; Susan R Heckbert; Bruce M Psaty; Sanjiv J Shah Journal: JCI Insight Date: 2020-10-02